Living With Lung Cancer: Ask Me Anything
Claim This Podcastby Lung Cancer Foundation of America
Podcast Overview
<p>Living with lung cancer isn't just about treatment plans and statistics—it's about the raw, real, messy truth of what it means to survive.</p> <p>No topic is off-limits. No question is too uncomfortable. No experience is too raw to share.</p>
Language
🇺🇲
Publishing Since
11/13/2025
Reach the team behind Living With Lung Cancer: Ask Me Anything
Verified contact details for this show aren't on file yet — sign up to get notified when they land.
Recent Episodes
May 28, 2026
SubQ: A Simpler, Less Disruptive Path to Lung Cancer Treatment
What if "one more medication" didn't have to feel like another punch? Host James Hiter sits down with ALK+ lung cancer survivor and patient advocate Stephanie Williams to demystify subcutaneous (SubQ) treatment delivery. Diagnosed at 37 with stage 2 non-small cell lung cancer, Stephanie brings both her patient experience and her background as a registered nurse to this conversation. She explains what SubQ delivery is, how it compares to traditional IV infusion, what to expect during an injection, and why this option can mean less anxiety, fewer infection risks, and more time back with family. You'll also hear Stephanie's clear, compassionate advice for the newly diagnosed: get biomarker testing, seek a second opinion, and connect with others who've walked this road. Whether you're a patient, caregiver, or simply curious about how lung cancer treatment is evolving, this episode offers practical insight and a hopeful look at where care is headed. Guests: Stephanie Williams, Patient Advocate, LCFA's Speakers Bureau Host: James Hiter, Patient Advocate, LCFA Board Member READY TO TALK TO YOUR DOCTOR ABOUT SubQ? Download LCFA's free SubQ Conversation Toolkit — it includes a Treatment Delivery FAQ, a SubQ vs. IV infographic, and a Conversation Guide built specifically for your next appointment. Bring it with you and start the conversation with confidence. Get your free toolkit at: https://lcfamerica.org/about-lung-cancer/treatment/subcutaneous-delivery/ Transcript Link: https://lcfamerica.org/wp-content/uploads/2026/05/LCFA-AMA-SubQ-Simpler-Way-Transcript.pdf Show Notes Link: https://lcfamerica.org/wp-content/uploads/2026/05/LCFA-AMA-SubQ-Simpler-Way-Show-Notes.pdf Video: https://youtu.be/8UgbxAmuY0U
May 14, 2026
14 Years Strong: Lysa Buonanno on Clinical Trials, ROS1, and Living Long-Term with Lung Cancer
What does 14 years of living with stage 4 lung cancer actually look like? Host Annabelle Gurwitch welcomes patient advocate, mentor, and new grandmother Lysa Buonanno for a deeply honest conversation about long-term survival with ROS1-positive lung cancer. Diagnosed at age 40 before biomarker testing was standard of care, Lysa learned about precision medicine through an online patient group, not her doctor. That knowledge led her to switch oncologists, undergo surgery for biomarker testing, and ultimately access targeted therapy that gave her five more years before progression. Today, she's on her fifth line of treatment via a Phase 1 clinical trial. Annabelle and Lysa dive into: The hidden realities of clinical trial participation (travel, reimbursement, the famous "$20 airport lunch") Why lung cancer trials don't use placebos The life-changing power of patient community and biomarker-specific support groups Why second opinions matter—and what to say to your doctor How identity shifts after a serious diagnosis Why we say "the drug failed the patient," not the patient failed the drug Becoming a grandmother after a terminal diagnosis Whether you're newly diagnosed, considering a clinical trial, or supporting a loved one with lung cancer, this episode delivers practical wisdom, scientific insight, and genuine hope. Guests: Lysa Buonanno, patient advocate and 14-year ROS1 lung cancer survivor Annabelle Gurwitch – Host, Author, and Patient AdvocateNew York Times bestselling author and LCFA Speakers Bureau member living with stage 4 EGFR+ lung cancer. Annabelle brings compassion, wit, and unflinching honesty to conversations about the real challenges of living with lung cancer. Diagnosed five years ago, she uses her platform to advocate for patients and raise awareness about treatment advances.Connect: https://www.annabellegurwitch.com/ | @annabellegurwitchLCFA Profile: https://lcfamerica.org/speaker-profile/annabelle-gurwitch/ Show Notes: https://lcfamerica.org/wp-content/uploads/2026/05/LCFA-AMA-Living-Long-Term-w-Lung-Cancer-Show-Notes.pdf Transcript: https://lcfamerica.org/wp-content/uploads/2026/05/LCFA-AMA-Living-Long-Term-w-Lung-Cancer-Transcript.pdf Video: Resources: LCFA Website: https://lcfamerica.org Living With Lung Cancer AMA Podcast: https://lcfamerica.org/living-with-lung-cancer/ask-me-anything/ LCFA Speakers Bureau: https://lcfamerica.org/speakers-bureau/ LCFA Second Opinion Resources: https://lcfamerica.org/resources/second-opinion/ Biomarker Testing Information: https://lcfamerica.org/lung-cancer-info/diagnosing-lung-cancer/biomarker-testing/ Treatment Options Overview: https://lcfamerica.org/lung-cancer-info/treatment/ Elevate Lung Cancer Care - Learn about your advanced ROS1+ or ALK+ non-small cell lung cancer (NSCLC) diagnosis and ways to navigate care plan discussions - https://elevatelungcancercare.com/
April 30, 2026
Scanxiety: Managing Drug Resistance Fears with ALK+ Patient Jaymie Knox
What goes through your mind in the days before a lung cancer scan? In this honest conversation, host James Hiter talks with ALK+ patient advocate Jaymie Knox about scanxiety, drug resistance, and the mental gymnastics of living with targeted therapy. Now seven years into treatment with alectinib, Jaymie shares why having a Plan B matters, how she keeps cancer from taking over her headspace, and why the language we use, "the medication failed me," not the other way around, makes a real difference for patients. Together, James and Jaymie talk about: Why drug resistance doesn't have to be the end of the road How scanxiety changes over years of treatment Practical ways to cope before, during, and after scans The power of a strong care team and a clear Plan B Hope grounded in real science and real options Whether you're newly diagnosed or a long-term survivor, this episode offers honest encouragement for the road ahead. Guests: Jaymie KnoxVoices of Hope Speakers Bureau Member | ALK+ Survivor & Advocate Jaymie was diagnosed with stage 4 ALK-positive lung cancer in December 2018 at age 32 — newly married and ready to start the next chapter of her life. Her first doctor failed to stage her cancer or explain what lay ahead. She fought for better care and never looked back. Now living in Washington, D.C., Jaymie recently fulfilled a lifelong dream of becoming a foster mom to two young children. She is a passionate advocate for mental health awareness in the lung cancer community and lives by a simple philosophy: "Have your moment, then turn the page." James HiterEndurance Athlete | Voices of Hope Speakers Bureau Member | Survivor James brings curiosity, determination, and hard-won wisdom to conversations about living with lung cancer. Diagnosed in 2017 with a rare multicystic presentation, he’s undergone three lung surgeries and now operates on roughly 55% of his original lung capacity—yet he still runs every single day. His journey through multidisciplinary tumor boards, second opinions, and ongoing surveillance gives him an intimate understanding of what patients and caregivers face. James asks the questions patients actually want answered because he’s wondered them himself. Show Notes - https://lcfamerica.org/wp-content/uploads/2026/04/LCFA-AMA-Scanxiety-Managing-Drug-Resistance-Fears-Notes.pdf Transcript - https://lcfamerica.org/wp-content/uploads/2026/04/LCFA-AMA-Drug-Resistance-Scanxiety-Transcript.pdf Watch the video - https://youtu.be/O6F_OLwjRHM
12 total episodes available
Similar Podcasts
Discover related shows you might enjoy
Deep-dive analytics for Living With Lung Cancer: Ask Me Anything
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is Living With Lung Cancer: Ask Me Anything?
<p>Living with lung cancer isn't just about treatment plans and statistics—it's about the raw, real, messy truth of what it means to survive.</p> <p>No topic is off-limits. No question is too uncomfortable. No experience is too raw to share.</p> - How often does this podcast release new episodes?
This podcast updates daily.
- Where can I listen to this podcast?
This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Yes, this podcast regularly features guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.